Cellectar Biosciences, Inc.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: US15117F8077

USD

3.77

-0.03 (-0.79%)

Dec 05

NAS

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

TherapeuticsMD, Inc.

Journey Medical Corp.

ASP Isotopes, Inc.

Aligos Therapeutics, Inc.

ARCA biopharma, Inc.

Checkpoint Therapeutics, Inc.

Corbus Pharmaceuticals Holdings, Inc.

BeyondSpring, Inc.

Cellectar Biosciences, Inc.

Qilian International Holding Group Ltd.

Apollomics, Inc.

Why is Cellectar Biosciences, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Cellectar Biosciences, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Cellectar Biosciences, Inc.

-90.76%

-0.00

3173.54%

S&P 500

12.66%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-189.66%

EBIT to Interest (avg)

-28.39

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.43

Sales to Capital Employed (avg)

Tax Ratio

0.18%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

36.77%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.73

EV to EBIT

-0.06

EV to EBITDA

-0.06

EV to Capital Employed

-0.67

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-549.62%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

ROCE(HY)

Highest at -273.88%

OPERATING PROFIT(Q)

Highest at USD -5.98 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

PRE-TAX PROFIT(Q)

Highest at USD -5.95 MM

NET PROFIT(Q)

Highest at USD -5.95 MM

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Cellectar Biosciences, Inc.

Operating Profit

Highest at USD -5.98 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite positive

Operating Profit (USD MM)

Pre-Tax Profit

Highest at USD -5.95 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit

At USD -5.95 MM has Grown at 55.52%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

Highest at USD -5.95 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Net Profit

At USD -5.95 MM has Grown at 55.52%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales